MedPath

University of Pavia

University of Pavia logo
🇮🇹Italy
Ownership
Private
Established
1361-01-01
Employees
1K
Market Cap
-
Website
http://www.unipv.it

Triple Therapy in Type 2 Diabetic Patients

Phase 4
Conditions
Type 2 Diabetes Mellitus
Interventions
First Posted Date
2013-07-10
Last Posted Date
2013-07-10
Lead Sponsor
University of Pavia
Target Recruit Count
64
Registration Number
NCT01895569
Locations
🇮🇹

IRCCS Policlinico S. Matteo Foundation, Pavia, Italy

Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria

Phase 3
Conditions
Hypertension
Type 2 Diabetes Mellitus
Microalbuminuria
Interventions
First Posted Date
2010-10-28
Last Posted Date
2010-10-28
Lead Sponsor
University of Pavia
Target Recruit Count
206
Registration Number
NCT01230034
Locations
🇮🇹

University of Pavia, Pavia, Italy

Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

Completed
Conditions
Diabetes
End Stage Renal Disease
Interventions
Device: Continuous Glucose Monitoring (CGM)
First Posted Date
2010-01-14
Last Posted Date
2022-05-24
Lead Sponsor
University of Pavia
Target Recruit Count
36
Registration Number
NCT01049152
Locations
🇮🇹

IRCCS Policlinico San Matteo, Pavia, Italy

Prevalence and Risk Factors of Erectile Dysfunction in Type 2 Diabetic Patients

Completed
Conditions
Type 2 Diabetic Patients
Erectile Dysfunction
Interventions
Other: type 2 diabetic patients
First Posted Date
2010-01-14
Last Posted Date
2015-03-17
Lead Sponsor
University of Pavia
Target Recruit Count
220
Registration Number
NCT01049750
Locations
🇮🇹

IRCCS Policlinico San Matteo, Pavia, Italy

Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients

Phase 4
Conditions
Hypertension
Interventions
Drug: aliskiren/amlodipine
First Posted Date
2010-01-13
Last Posted Date
2010-01-13
Lead Sponsor
University of Pavia
Target Recruit Count
88
Registration Number
NCT01048047
Locations
🇮🇹

University of Pavia, Pavia, Italy

Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria

Phase 4
Conditions
Hypertension
Type 2 Diabetes
Interventions
Drug: Experimental
First Posted Date
2009-12-24
Last Posted Date
2009-12-24
Lead Sponsor
University of Pavia
Target Recruit Count
120
Registration Number
NCT01038895
Locations
🇮🇹

University of Pavia, Pavia, PV, Italy

Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

Phase 4
Conditions
Essential Hypertension
Interventions
Drug: valsartan/amlodpine
Drug: losartan/amlodpine
First Posted Date
2008-07-16
Last Posted Date
2008-07-17
Lead Sponsor
University of Pavia
Target Recruit Count
187
Registration Number
NCT00716950
Locations
🇮🇹

Giuseppe Derosa, Pavia, Italy

Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis

Phase 4
Conditions
Hypertension
Interventions
First Posted Date
2008-04-30
Last Posted Date
2008-04-30
Lead Sponsor
University of Pavia
Target Recruit Count
75
Registration Number
NCT00669435
Locations
🇮🇹

University of Pavia, Pavia, Italy

Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular

Phase 3
Conditions
Essential Hypertension
Diabetes Mellitus
Interventions
First Posted Date
2008-04-16
Last Posted Date
2008-04-16
Lead Sponsor
University of Pavia
Target Recruit Count
100
Registration Number
NCT00659451
Locations
🇮🇹

University of Pavia, Pavia, Italy

Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

Phase 3
Conditions
Essential Hypertension
Interventions
First Posted Date
2008-03-26
Last Posted Date
2008-03-26
Lead Sponsor
University of Pavia
Target Recruit Count
60
Registration Number
NCT00644475
Locations
🇮🇹

University of Pavia, Pavia, Italy

© Copyright 2025. All Rights Reserved by MedPath